Home › Billing code M0249
M0249
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
Medicaid paid $29.63 on code M0249 from 2018 through 2024, to 2 providers — the #9,394 code in the file by dollars. 100% of it was billed in Texas.
28Total paid$29.63
24GClaims50
Paid per claim line$0.59
33Providers billing it2
Box 32 · Location
Where M0249 is billed
The largest of 1 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.
Ranked
Top providers billing M0249
| # | Provider | Location | Claims | Paid on M0249 |
|---|---|---|---|---|
| 1 | Educare Community Living Corporation - Texas | Austin, TX | 37 | $29.63 |
| 2 | Ikids Pediatric Care PLLC | Fort Worth, TX | 13 | $0.00 |